Skip to content

Medical-device intelligence

OZX: Mycoplasma Pneumoniae Dna Assay System

FDA product code OZX: Mycoplasma Pneumoniae Dna Assay System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OZX
FDA device name
Mycoplasma Pneumoniae Dna Assay System
Device class
2
Regulation number
866.3980
Medical specialty
Microbiology
Review panel
MI

FDA definition

A qualitative in vitro diagnostic assay intended to detect Mycoplasma pneumoniae DNA extracted from human respiratory specimens. Detection of Mycoplasma pneumoniae DNA aids in the diagnosis of Mycoplasma pneumoniae respiratory infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infection.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jun 5, 2013 to Jun 13, 2016.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OZX · Mycoplasma Pneumoniae Dna Assay System30

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10K160829 · OZXMeridian Bioscience, Inc.510(k)Jun 13, 2016FDA decision date
illumigene Mycoplasma DNA Amplification AssayK152800 · OZXMeridian Bioscience, Inc.510(k)Oct 23, 2015FDA decision date
ILLUMIGENE MYCOPLASAMA DNA AMPLIFICATION ASSAY, AND ILLUMIGENE MYCOPLASMA EXTERNAL CONTROLS KITK123423 · OZXMeridian Bioscience, Inc.510(k)Jun 5, 2013FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗